Magnetic resonance imaging of anal cancer: tumor characteristics and early prediction of treatment outcome

Strahlenther Onkol. 2024 Jan;200(1):19-27. doi: 10.1007/s00066-023-02114-5. Epub 2023 Jul 10.

Abstract

Purpose: To analyze tumor characteristics derived from pelvic magnetic resonance imaging (MRI) of patients with squamous cell carcinoma of the anus (SCCA) before and during chemoradiotherapy (CRT), and to compare the changes in these characteristics between scans of responders vs. nonresponders to CRT.

Methods: We included 52 patients with a pelvic 3T MRI scan prior to CRT (baseline scan); 39 of these patients received an additional scan during week 2 of CRT (second scan). Volume, diameter, extramural tumor depth (EMTD), and external anal sphincter infiltration (EASI) of the tumor were assessed. Mean, kurtosis, skewness, standard deviation (SD), and entropy values were extracted from apparent diffusion coefficient (ADC) histograms. The main outcome was locoregional treatment failure. Correlations were evaluated with Wilcoxon's signed rank-sum test and Pearson's correlation coefficient, quantile regression, univariate logistic regression, and area under the ROC curve (AUC) analyses.

Results: In isolated analyses of the baseline and second MRI scans, none of the characteristics were associated with outcome. Comparison between the scans showed significant changes in several characteristics: volume, diameter, EMTD, and ADC skewness decreased in the second scan, although the mean ADC increased. Small decreases in volume and diameter were associated with treatment failure, and these variables had the highest AUC values (0.73 and 0.76, respectively) among the analyzed characteristics.

Conclusion: Changes in tumor volume and diameter in an early scan during CRT could represent easily assessable imaging-based biomarkers to eliminate the need for analysis of more complex MRI characteristics.

Keywords: Anal cancer; Area under the curve; Biomarker; Chemoradiotherapy; Diffusion magnetic resonance imaging.

MeSH terms

  • Anus Neoplasms* / diagnostic imaging
  • Anus Neoplasms* / therapy
  • Chemoradiotherapy / methods
  • Diffusion Magnetic Resonance Imaging / methods
  • Humans
  • Magnetic Resonance Imaging / methods
  • Rectal Neoplasms* / pathology
  • Retrospective Studies
  • Treatment Outcome